Literature DB >> 24914073

Obstructive sleep apnoea syndrome in patients with primary open-angle glaucoma.

Ege G Balbay1, Oner Balbay1, Ali N Annakkaya1, Kezban O Suner1, Harun Yuksel2, Murat Tunç2, Peri Arbak1.   

Abstract

OBJECTIVE: To investigate the prevalence of obstructive sleep apnoea syndrome in patients with primary open-angle glaucoma.
DESIGN: Case series.
SETTING: School of Medicine, Düzce University, Turkey. PATIENTS: Twenty-one consecutive primary open-angle glaucoma patients (12 females and 9 males) who attended the out-patient clinic of the Department of Ophthalmology between July 2007 and February 2008 were included in this study. All patients underwent polysomnographic examination.
RESULTS: The prevalence of obstructive sleep apnoea syndrome was 33.3% in patients with primary open-angle glaucoma; the severity of the condition was mild in 14.3% and moderate in 19.0% of the subjects. The age (P=0.047) and neck circumference (P=0.024) in patients with obstructive sleep apnoea syndrome were significantly greater than those without the syndrome. Triceps skinfold thickness in glaucomatous obstructive sleep apnoea syndrome patients reached near significance versus those without the syndrome (P=0.078). Snoring was observed in all glaucoma cases with obstructive sleep apnoea syndrome. The intra-ocular pressure of patients with primary open-angle glaucoma with obstructive sleep apnoea syndrome was significantly lower than those without obstructive sleep apnoea syndrome (P=0.006 and P=0.035 for the right and left eyes, respectively). There was no significant difference in the cup/disc ratio and visual acuity, except visual field defect, between primary open-angle glaucoma patients with and without obstructive sleep apnoea syndrome.
CONCLUSIONS: Although it does not provide evidence for a cause-effect relationship, high prevalence of obstructive sleep apnoea syndrome in patients with primary open-angle glaucoma in this study suggests the need to explore the long-term results of coincidence, relationship, and cross-interaction of these two common disorders.

Entities:  

Keywords:  Glaucoma, open-angle; Sleep apnea, obstructive; Turkey

Mesh:

Year:  2014        PMID: 24914073     DOI: 10.12809/hkmj134021

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN: 1024-2708            Impact factor:   2.227


  6 in total

1.  ipRGCs: possible causation accounts for the higher prevalence of sleep disorders in glaucoma patients.

Authors:  Zhen-Zhen Guo; Shan-Ming Jiang; Li-Ping Zeng; Li Tang; Ni Li; Zhu-Ping Xu; Xin Wei
Journal:  Int J Ophthalmol       Date:  2017-07-18       Impact factor: 1.779

Review 2.  Glaucoma and its association with obstructive sleep apnea: A narrative review.

Authors:  Aditya Chaitanya; Vijaya H Pai; Aswini Kumar Mohapatra; Ramesh S Ve
Journal:  Oman J Ophthalmol       Date:  2016 Sep-Dec

3.  Obstructive sleep apnea as a risk factor for primary open angle glaucoma and ocular hypertension in a monocentric pilot study.

Authors:  Katharina Bahr; Michael Bopp; Waeel Kewader; Henri Dootz; Julia Döge; Tilman Huppertz; Perikles Simon; Verena Prokosch-Willing; Christoph Matthias; Haralampos Gouveris
Journal:  Respir Res       Date:  2020-10-08

4.  Prevalence of Obstructive Sleep Apnea in Glaucoma Patients: A Systematic Review and Meta-analysis.

Authors:  Brian E Yu; Ronald Cheung; Cindy Hutnik; Monali S Malvankar-Mehta
Journal:  J Curr Glaucoma Pract       Date:  2021 Sep-Dec

5.  Prospective evaluation of the comorbidity of obstructive sleep apnea in patients with glaucoma.

Authors:  Yuan-Hsi Chan; Lan-Hsin Chuang; Chung-Chieh Yu; Yu-Lun Lo; Henry S L Chen; Pei-Wei Huang; Ling Yeung; Chi-Chun Lai
Journal:  J Clin Sleep Med       Date:  2022-01-01       Impact factor: 4.062

Review 6.  Ginkgo Biloba Extract in Ophthalmic and Systemic Disease, With a Focus on Normal-Tension Glaucoma.

Authors:  Margarita Labkovich; Erica B Jacobs; Siddharth Bhargava; Louis R Pasquale; Robert Ritch
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2020 May-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.